FIGURE 3.
Prognostic analysis of the PRR lncRNAs signature in the total, training cohort, and testing group. (A–C) Kaplan–Meier curve of the patient in the whole, training cohort, and testing groups. (D–F) The rank of calculated risk scores in the total, training cohort, and testing groups. (G–I) Heatmap showed the differences of 8 PRR lncRNAs in the whole, training cohort, and testing groups. (J–L) Time-independent receiver operating characteristic (ROC) analysis in the total, training cohort, and testing groups.
